Call for your appointment today 914-666-4665 | Mt. Kisco, New York
Neuropsychiatric Disorders
What is PANS?
Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is a type of autoimmune encephalopathy (AE) or basal ganglia encephalitis (BGE). This syndrome, often triggered by infections, results in the sudden onset of certain neuropsychiatric symptoms and behavioral changes.
What is PANS?
Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is an immune-mediated syndrome that affects the basal ganglia region of the brain. This condition, often triggered by infections, can result in neuroinflammation (encephalitis) and the onset of neuropsychiatric symptoms such as obsessions/compulsions, restrictive eating, tics, anxiety and ADHD-like behaviors.
PANS syndrome occurs when the body’s immune system is misdirected in response to an infection. A dysfunctional immune system can produce autoantibodies which mistakenly target healthy proteins or receptors in the brain, such as dopamine receptors, lysoganglioside and tubulin. This misdirected attack can also lead to neuroinflammation, that in turn can disrupt certain cell functioning and trigger various neurologic and psychiatric symptoms.
PANS: Neuropsychiatric Symptoms
PANS: Neuropsychiatric Symptoms
PANS is a broader clinical diagnostic category which includes PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections). PANS and PANDAS are immune-mediated conditions that result in autoimmune encephalopathy (AE) or basal ganglia encephalitis (BGE). However, while PANDAS is a disorder that is preceded by a strep infection, PANS is a syndrome which may be triggered by other infections or even environmental triggers.
PANS symptoms can vary from person to person, range in severity, but follows a relapsing/remitting course.
This syndrome is characterized by an abrupt onset of obsessive-compulsive behaviors or restrictive eating accompanied by other neuropsychiatric symptoms which may include anxiety, emotional lability, depression, irritability, aggression, oppositional behavior, deterioration in school performance, behavioral (developmental) regression, sensory amplification, movement abnormalities, sleep disturbance, and urinary frequency. 1
PANS symptoms can vary from person to person, range in severity, but follows a relapsing/remitting course.
This syndrome is characterized by an abrupt onset of obsessive-compulsive behaviors or restrictive eating accompanied by other neuropsychiatric symptoms which may include anxiety, emotional lability, depression, irritability, aggression, oppositional behavior, deterioration in school performance, behavioral (developmental) regression, sensory amplification, movement abnormalities, sleep disturbance, and urinary frequency. 1
“PANS symptoms overlap with a variety of psychiatric disorders, such as OCD, Tourette’s syndrome, ADHD, depression, and bipolar disorder. However, the acuity of onset and simultaneous presentation of these symptoms differentiate PANS from these psychiatric conditions.” 1
Could your symptoms be due to an immune dysfunction?
Take our quiz and see if your symptoms may be due to an underlying autoimmune dysfunction and if testing may be right for you.
Take Our Quiz
Answer a few questions to find out if you might benefit from testing with the Autoimmune Brain Panel™.
Learn More About Testing
Are you struggling with neurological symptoms? It may be due to an autoimmune response.
Infections associated with the onset of PANS
A number of infections have been associated with the onset of PANS including upper respiratory infections, such as rhinosinusitis, pharyngitis, or bronchitis, mycoplasma pneumoniae, influenza, Epstein Barr virus, Borrelia burgdorferi (Lyme disease), herpes simplex infection and varicella. 2
Researchers now recognize that infections and inflammation can open up the blood-brain barrier, permitting autoantibodies to enter the brain, resulting in neurologic and psychiatric symptoms. 3
In PANS and PANDAS, autoantibodies target components located in the basal ganglia region of the brain. These targets may include the Dopamine D1 receptor, Dopamine D2 receptor, Lysoganglioside GM1, and Tubulin. When antibodies bind to or block these targets they disrupt functioning, resulting in neuropsychiatric symptoms. 2
References
- Kiki Chang, Jennifer Frankovich, Michael Cooperstock, Madeleine W. Cunningham, M. Elizabeth Latimer, Tanya K. Murphy, Mark Pasternack, Margo Thienemann, Kyle Williams, Jolan Walter, Susan E. Swedo, and From the PANS Collaborative Consortium.Journal of Child and Adolescent Psychopharmacology.Feb 2015.3-13.http://doi.org/10.1089/cap.2014.0084 https://www.liebertpub.com/doi/full/10.1089/cap.2014.0084
- Chain JL, Alvarez K, Mascaro-Blanco A, et al. Autoantibody Biomarkers for Basal Ganglia Encephalitis in Sydenham Chorea and Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infections. Front Psychiatry. 2020;11:564. Published 2020 Jun 24. doi:10.3389/fpsyt.2020.00564 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328706/
- Benros ME, Waltoft BL, Nordentoft M, et al. Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders: A Nationwide Study. JAMA Psychiatry. 2013;70(8):812–820. doi:10.1001/jamapsychiatry.2013.1111 https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1696348
Learn about PANS & PANDAS and the Autoimmune Brain Panel™
